ReVision Optics, Inc.: Series D $35M

Posted in I - Series D, Q - 2Q10, R - WEST, X - Device (Ophthalmology), XX - CA

ReVision Optics (Lake Forest, CA) a clinical-stage medical device company focused on a corneal inlay for presbyopia, closed a $35M Series D financing. Participants include ProQuest Investments, Domain Associates, Canaan Partners and InterWest Partners.

Mar

2010

MicroCHIPS, Inc.: Series C $16.5M

Posted in I - Series C, Q - 1Q10, R - NORTH EAST, X - Device (Delivery), X - Device (Diabetes), X - Device (Osteoporosis), XX - MA

MicroCHIPS (Bedford, MA) a development-stage medical device company focused on implantable drug delivery and biosensing for diabetes and osteoporosis, closed a $16.5M Series C financing. Participants include InterWest Partners, Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital.

Jan

2010

Integrated Diagnostics, Inc.: Series A $30M

Posted in I - Series A, Q - 4Q09, R - NORTH WEST, X - Device (Diagnostic), XX - WA

Integrated Diagnostics (Seattle, WA) a development-stage diagnostics company focused on rapid biomarker validation and parallel organ-centric assays, closed a $30M Series A financing. Participants include Interwest Partners, The Wellcome Trust and Dievini Hopp Biotech Holding.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Oct

2009

PrimeraDx, Inc.: Series C $20M

Posted in I - Series C, Q - 3Q09, R - NORTH EAST, X - Antiinfective, X - Device (Diagnostic), XX - MA

PrimeraDx (Mansfield, MA) a development-stage molecular diagnostics company focused on automated multiplexed assays of infectious disease testing in immune compromised patients undergoing solid organ and bone marrow transplant, closed a $20M Series C financing. Participants include CHL Medical Partners, Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Co. and Invus.

to top of page...